Nabriva Therapeutics plc Contracts & Agreements

89 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Asset Purchase Agreement, dated as of July 30, 2023, by and among Nabriva Therapeutics plc, Nabriva Therapeutics Ireland DAC, Nabriva Therapeutics US, Inc., Nabriva Therapeutics...
Purchase Agreements
Nabriva Therapeutics plc
2023
Separation and Release of Claims Agreement, by and between Nabriva Therapeutics US, Inc. and Daniel Dolan
Separation Agreements
Nabriva Therapeutics plc
2023
Separation and Release of Claims Agreement, by and between Nabriva Therapeutics US, Inc. and J. Christopher Naftzger
Separation Agreements
Nabriva Therapeutics plc
2023
Consulting Agreement, by and between Nabriva Therapeutics US, Inc. and Daniel Dolan
Consulting Agreements
Nabriva Therapeutics plc
2023
Consulting Agreement, by and between Nabriva Therapeutics US, Inc. and J. Christopher Naftzger
Consulting Agreements
Nabriva Therapeutics plc
2023
Separation and Release of Claims Agreement, by and between Nabriva Therapeutics US, Inc. and Christine Guico-Pabia
Separation Agreements
Nabriva Therapeutics plc
Pharmaceuticals
PA
2023
Consulting Agreement, by and between Nabriva Therapeutics US, Inc. and Christine Guico-Pabia
Consulting Agreements
Nabriva Therapeutics plc
2023
Third Amendment to API Supply Agreement, dated November 11, 2022, by and between Nabriva Therapeutics Ireland Designated Activity Company and Hovione Limited
Supply Agreements
Nabriva Therapeutics plc
2023
Letter Agreement, dated January 31, 2023, by and among Nabriva Therapeutics Ireland Designated Activity Company, MSD International Business GmbH and Merck Sharp & Dohme LLC
Nabriva Therapeutics plc
2023
Separation and Release of Claims Agreement, by and between Nabriva Therapeutics US, Inc. and Theodore Schroeder
Separation Agreements
Nabriva Therapeutics plc
2023
Separation and Release of Claims Agreement, by and between Nabriva Therapeutics US, Inc. and Steven Gelone
Separation Agreements
Nabriva Therapeutics plc
2023
Consulting Agreement, by and between Nabriva Therapeutics US, Inc. and Theodore Schroeder
Consulting Agreements
Nabriva Therapeutics plc
Pharmaceuticals
PA
2023
Consulting Agreement, by and between Nabriva Therapeutics US, Inc. and Steven Gelone
Consulting Agreements
Nabriva Therapeutics plc
Pharmaceuticals
PA
2023
Third Amendment to Sales Promotion and Distribution Agreement, dated as of July 15, 2020, by and among Nabriva Therapeutics Ireland Designated Activity Company, MSD International...
Sales Agreements
Nabriva Therapeutics plc
2022
Form of Contingent RSU Award Agreement under the 2020 Share Incentive Plan, as amended
Bonus & Incentive Agreements
Nabriva Therapeutics plc
2022
Side Agreement to Manufacturing Services Agreement, dated November 19, 2021, by and among Nabriva Therapeutics Ireland DAC and Patheon UK Ltd
Services Agreements
Nabriva Therapeutics plc
2022
Employment Agreement dated August 24, 2021 by and between Nabriva Therapeutics US, Inc. and J. Christopher Naftzger
Employment Agreements
Nabriva Therapeutics plc
2021
Employment Agreement dated August 23, 2021 by and between Nabriva Therapeutics US, Inc. and Christine Guico-Pabia
Employment Agreements
Nabriva Therapeutics plc
2021
2021 Inducement Share Incentive Plan, as amended
Bonus & Incentive Agreements
Nabriva Therapeutics plc
2021
Registration Rights Agreement dated September 24, 2021 between Nabriva Therapeutics plc and Lincoln Park Capital Fund, LLC
Registration Rights Agreements
Nabriva Therapeutics plc
2021
Purchase Agreement dated September 24, 2021 between Nabriva Therapeutics plc and Lincoln Park Capital Fund, LLC
Purchase Agreements
Nabriva Therapeutics plc
2021
Fourth Amendment to Loan and Security Agreement, dated as of June 2, 2021, by and among Nabriva Therapeutics Public Limited Company, Nabriva Therapeutics Ireland Designated...
Loan Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NY
2021
Assignment, Assumption and Novation agreement, by and among Nabriva Therapeutics Ireland Designated Activity Company, Nabriva Therapeutics GmbH, Roivant Sciences Ltd., Roivant...
Assignment Agreements
Nabriva Therapeutics plc
2021
First Amendment to Sales Promotion and Distribution Agreement, dated as of July 15, 2020, by and among Nabriva Therapeutics Ireland Designated Activity Company, MSD International...
Sales Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NJ
2021
Second Amendment to Sales Promotion and Distribution Agreement, dated as of April 12, 2021, by and among Nabriva Therapeutics Ireland Designated Activity Company, MSD...
Sales Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NJ
2021
First Amendment to API Supply Agreement, dated August 4, 2021, by and between Nabriva Therapeutics Ireland Designated Activity Company and Hovione Limited
Supply Agreements
Nabriva Therapeutics plc
Pharmaceuticals
2021
Consulting Agreement, dated May 3, 2021, by and between Nabriva Therapeutics US, Inc. and Jennifer Schranz
Consulting Agreements
Nabriva Therapeutics plc
Pharmaceuticals
PA
2021
Open Market Sale AgreementSM, dated May 6, 2021, by and between Nabriva Therapeutics plc and Jefferies LLC
Nabriva Therapeutics plc
Pharmaceuticals
NY
2021
Form of Share Option Agreement under the 2020 Share Incentive Plan, as amended
Bonus & Incentive Agreements
Nabriva Therapeutics plc
2021
Form of Restricted Share Unit Agreement under the 2020 Share Incentive Plan, as amended (Share Withholding)
Bonus & Incentive Agreements
Nabriva Therapeutics plc
Pharmaceuticals
DE
2021
Form of Restricted Share Unit Agreement under the 2020 Share Incentive Plan, as amended (Automatic Sale)
Bonus & Incentive Agreements
Nabriva Therapeutics plc
Pharmaceuticals
DE
2021
Form of Share Option Agreement under the 2021 Inducement Share Incentive Plan
Bonus & Incentive Agreements
Nabriva Therapeutics plc
2021
Description of the Registrants Securities Registered under Section 12 of the Exchange Act
Nabriva Therapeutics plc
2021
Amended and Restated Employment Agreement, by and between Nabriva Therapeutics US, Inc. and Robert Crotty, dated as of March 10, 2021
Employment Agreements
Nabriva Therapeutics plc
2021
Amended and Restated Employment Agreement, by and between Nabriva Therapeutics US, Inc. and Theodore Schroeder, dated as of March 10, 2021
Employment Agreements
Nabriva Therapeutics plc
Pharmaceuticals
CA
2021
Third Amended and Restated Employment Agreement by and between Nabriva Therapeutics US, Inc. and Steven Gelone, dated as of March 10, 2021
Employment Agreements
Nabriva Therapeutics plc
Pharmaceuticals
PA
2021
2021 Inducement Share Incentive Plan
Bonus & Incentive Agreements
Nabriva Therapeutics plc
Pharmaceuticals
DE
2021
Employment Agreement, by and between Nabriva Therapeutics US, Inc. and Daniel Dolan, dated as of March 10, 2021
Employment Agreements
Nabriva Therapeutics plc
2021
First Amendment to License Agreement, dated October 29, 2021, by and among Nabriva Therapeutics Ireland DAC, Sinovant Sciences, Ltd., Nabriva Therapeutics GmbH and Roivant...
License Agreements
Nabriva Therapeutics plc
2021
Consulting Agreement, by and between Nabriva Therapeutics US, Inc. and Sender Consulting LLC, dated as of March 9, 2021
Consulting Agreements
Nabriva Therapeutics plc
2021
Form of Ordinary Share Warrant
Warrant Agreements
Nabriva Therapeutics plc
Pharmaceuticals
2021
Form of Pre-Funded Warrant
Warrant Agreements
Nabriva Therapeutics plc
2021
Form of Securities Purchase Agreement, dated March 1, 2021, by and among Nabriva Therapeutics plc and the purchasers party thereto
Purchase Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NY
2021
Sublease Agreement, dated as of February 8, 2021, by and between Professional Payroll Solutions, LLC and Nabriva Therapeutics US, Inc
Lease Agreements
Nabriva Therapeutics plc
2021
Form of Securities Purchase Agreement, dated December 10, 2020, by and among Nabriva Therapeutics plc and the purchasers party thereto
Purchase Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NY
2020
Retention Agreement, dated August 5, 2020, by and between Nabriva Therapeutics US, Inc. and Jennifer Schranz
Retention Agreements
Nabriva Therapeutics plc
Pharmaceuticals
PA
2020
Sales Promotion and Distribution Agreement, dated as of July 15, 2020, by and among Nabriva Therapeutics Ireland Designated Activity Company, MSD International GmbH and Merck...
Sales Agreements
Nabriva Therapeutics plc
2020
Form of Warrant
Warrant Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NY
2020
Form of Securities Purchase Agreement, dated May 29, 2020, by and among Nabriva Therapeutics plc and the purchasers party thereto
Purchase Agreements
Nabriva Therapeutics plc
2020
Description of the Registrants Securities Registered under Section 12 of the Exchange Act
Nabriva Therapeutics plc
2020
Form of Restricted Share Unit Agreement under the 2017 Share Incentive Plan (Share Withholding)
Bonus & Incentive Agreements
Nabriva Therapeutics plc
Pharmaceuticals
DE
2020
Second Amendment to Loan and Security Agreement, dated as of January 8, 2020, by and among Nabriva Therapeutics Public Limited Company, Nabriva Therapeutics Ireland Designated...
Loan Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NY
2020
Third Amendment to Loan and Security Agreement, dated as of March 11, 2020, by and among Nabriva Therapeutics Public Limited Company, Nabriva Therapeutics Ireland Designated...
Loan Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NY
2020
2020 Share Incentive Plan
Bonus & Incentive Agreements
Nabriva Therapeutics plc
2020
Form of Share Option / Cash Settled Share Appreciation Right Agreement under the 2020 Share Incentive Plan
Bonus & Incentive Agreements
Nabriva Therapeutics plc
2020
Form of Warrant
Warrant Agreements
Nabriva Therapeutics plc
2019
Form of Securities Purchase Agreement, dated December 20, 2019, by and among Nabriva Therapeutics plc and the purchasers party thereto
Purchase Agreements
Nabriva Therapeutics plc
2019
First Amendment to Loan and Security Agreement, dated as of September 26, 2019, by and among Nabriva Therapeutics Public Limited Company, Nabriva Therapeutics Ireland Designated...
Loan Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NY
2019
Open Market Sale AgreementSM, dated June 25, 2019, by and between Nabriva Therapeutics plc and Jefferies LLC
Nabriva Therapeutics plc
Pharmaceuticals
NY
2019
Employment Agreement, by and between Nabriva Therapeutics US, Inc. and Jennifer Schranz, dated as of March 21, 2018
Employment Agreements
Nabriva Therapeutics plc
Pharmaceuticals
PA
2019
Agreement for the Commercial Supply of Products by and between Arran Chemical Company Limited and Nabriva Therapeutics Ireland DAC, dated as of November 12, 2018
Supply Agreements
Nabriva Therapeutics plc
Pharmaceuticals
2019
Active Pharmaceutical Ingredient Supply Agreement by and between Nabriva Therapeutics Ireland DAC and Hovione Limited, dated as of November 23, 2018
Supply Agreements
Nabriva Therapeutics plc
Pharmaceuticals
2019
Loan and Security Agreement, dated as of December 20, 2018, by and among Nabriva Therapeutics plc, Nabriva Therapeutics Ireland DAC, certain other subsidiaries of Nabriva...
Loan Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NY
2019
Stock Purchase Agreement by and among SG Pharmaceuticals, Inc., the Sellers named on Annex A, and Julia Feliciano, as Sellers Representative, dated as of May 5, 2015
Stock Agreements
Nabriva Therapeutics plc
Pharmaceuticals
CA
2018
License Agreement by and between ICPD Holdings, LLC and Evelyn J. Ellis-Grosse and Zavante Therapeutics, Inc., dated as of March 1, 2014
License Agreements
Nabriva Therapeutics plc
2018
Office Lease by and between AGP Sorrento R&D, LP and Zavante Therapeutics, Inc., dated as of June 16, 2016
Lease Agreements
Nabriva Therapeutics plc
2018
Manufacturing and Supply Agreement by and between Zavante Therapeutics, Inc. and Ercros, S.A., dated as of July 28, 2016
Supply Agreements
Nabriva Therapeutics plc
Pharmaceuticals
2018
Amended and Restated Three-Way Agreement by and between Laboratorios ERN, S.A, Ercros, S.A., and Zavante Therapeutics, Inc., dated as of July 28, 2016
Nabriva Therapeutics plc
Pharmaceuticals
2018
Amended and Restated Pharmaceutical Manufacturing and Exclusive Supply Agreement by and between Laboratorios ERN, S.A. and Zavante Therapeutics, Inc. dated as of July 28, 2016, as...
Supply Agreements
Nabriva Therapeutics plc
2018
Manufacturing and Supply Agreement by and between Zavante Therapeutics, Inc. and Fisiopharma, S.r.l., dated as of April 14, 2017
Supply Agreements
Nabriva Therapeutics plc
Pharmaceuticals
2018
Commercial Packaging Agreement by and between Zavante Therapeutics, Inc. and AndersonBrecon Inc., d/b/a PCI of Illinois, dated as of December 26, 2017
Nabriva Therapeutics plc
Pharmaceuticals
IL
2018
Packaging and Supply Agreement by and between Sharp Corporation and Nabriva Therapeutics US, Inc., dated as of August 30, 2018
Supply Agreements
Nabriva Therapeutics plc
Pharmaceuticals
PA
2018
Second Amended and Restated Employment Agreement by and between Nabriva Therapeutics US, Inc. and Steven Gelone, dated as of July 24, 2018
Employment Agreements
Nabriva Therapeutics plc
2018
Underwriting Agreement, dated July 26, 2018, by and among Nabriva Therapeutics plc and Morgan Stanley & Co. LLC, as representative of the underwriters named therein
Underwriting Agreements
Nabriva Therapeutics plc
2018
Agreement and Plan of Merger dated as of July 23, 2018, by and among Nabriva Therapeutics plc, Zuperbug Merger Sub I, Inc., Zuperbug Merger Sub II, Inc., Zavante Therapeutics,...
Merger Agreements
Nabriva Therapeutics plc
2018
Transition, Separation and Release of Claims Agreement, by and between Nabriva Therapeutics US, Inc. and Colin Broom, dated as of July 23, 2018
Separation Agreements
Nabriva Therapeutics plc
2018
Employment Agreement, by and between Nabriva Therapeutics US, Inc. and Theodore Schroeder, dated as of July 23, 2018
Employment Agreements
Nabriva Therapeutics plc
2018
License Agreement, dated March 26, 2018, by and among Nabriva Therapeutics Ireland DAC, Sinovant Sciences, Ltd., Nabriva Therapeutics GmbH and Roivant Sciences, Ltd
License Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NY
2018
Manufacturing Services Agreement, dated May 8, 2017, by and between Patheon UK Limited and Nabriva Therapeutics AG
Services Agreements
Nabriva Therapeutics plc
2018
Master Agreement for the Manufacture, Packaging and Supply of Products, dated August 7, 2017, by and between ALMAC Pharma Services Limited and Nabriva Therapeutics Ireland DAC
Supply Agreements
Nabriva Therapeutics plc
2018
Key Intermediate Supply Agreement, dated of August 28, 2017 by and among Nabriva Therapeutics Ireland DAC, and SEL Biochem Xinjiang Co., Ltd, and Fountain International...
Development Agreements
Nabriva Therapeutics plc
Pharmaceuticals
2018
Controlled Equity OfferingSM Sales Agreement, dated March 16, 2018, by and between Nabriva Therapeutics plc and Cantor Fitzgerald & Co
Sales Agreements
Nabriva Therapeutics plc
2018
Form of Restricted Share Unit Agreement under the 2017 Share Incentive Plan
Bonus & Incentive Agreements
Nabriva Therapeutics plc
Pharmaceuticals
DE
2018
Form of Share Option Agreement under the 2017 Share Incentive Plan
Bonus & Incentive Agreements
Nabriva Therapeutics plc
2018
2017 Share Incentive Plan
Bonus & Incentive Agreements
Nabriva Therapeutics plc
2017
Underwriting Agreement, dated September 19, 2017, by and among Nabriva Therapeutics plc and Morgan Stanley & Co. LLC and Merrill Lynch, Pierce, Fenner & Smith Incorporated, as...
Underwriting Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NY
2017
SEPARATION AND RELEASE OF CLAIMS AGREEMENT
Separation Agreements
Nabriva Therapeutics plc
Pharmaceuticals
PA
2017
EMPLOYMENT AGREEMENT
Employment Agreements
Nabriva Therapeutics plc
Pharmaceuticals
PA
2017
EMPLOYMENT AGREEMENT
Employment Agreements
Nabriva Therapeutics plc
Pharmaceuticals
PA
2017